Saccharin

DIETARY_SUPPLEMENT4 trials

Sponsors

Lund University, Weizmann Institute of Science, National University of Malaysia, Charite University, Berlin, Germany

Conditions

Cardiovascular (CV) RiskCardiovascular Diseases (CVD)Cardiovascular Risk FactorsGlucose IntoleranceGlucose, High BloodGlucose, Low BloodHealthy SubjectsHypercoagulable State

Unknown Phase

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

CompletedNCT02580110

Lund UniversityHealthy Subjects

Start: 2015-10-31End: 2016-06-30Updated: 2016-06-23

Microbiome and Non-caloric Sweeteners in Humans

CompletedNCT03708939

Weizmann Institute of ScienceGlucose, High Blood, Glucose Intolerance, Glucose, Low Blood

Start: 2017-02-19End: 2021-01-01Updated: 2021-08-04

Short-Term Effects of Sucralose and Saccharin on Blood Sugar and Gut Microbiota in Type 2 Diabetes

Not yet recruitingNCT07124585

National University of MalaysiaType 2 Diabetes Mellitus (T2DM)

Start: 2026-01-30End: 2027-07-31Target: 33Updated: 2025-12-10

Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects

Not yet recruitingNCT07377097

Charite University, Berlin, GermanyCardiovascular (CV) Risk, Cardiovascular Diseases (CVD), Cardiovascular Risk Factors +8

Start: 2026-01-05End: 2026-11-01Target: 80Updated: 2026-01-29

Related Papers

Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial.

2025-12-10

Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial (Preprint)

2025-08-20